AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2016
Oct 4, 2016
33899_dirs_2016-10-04_941c9ef6-afc0-4bc8-a739-5c83a1e8f43f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2016-10-03
Reporting Person: Chard Daniel R (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-03 | Common Stock | A | 16061 | — | Acquired | 16061 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-10-03 | Performance-based deferred shares | $ | A | 210000 | Acquired | 2019-12-31 | Common Stock (210000) | Direct |
Footnotes
F1: These shares will vest one-third per year on each of the first, second and third anniversaries of the grant date.
F2: Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock.
More from MEDIFAST INC
Board/Management Information
2026
Jun 1
Board/Management Information
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Board/Management Information
2026
Mar 20